LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
HAYWARD, Calif., June 2, 2011 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The Company expects to grant the underwriters...
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.